Venrock Healthcare Capital Partners III, L.P. - Feb 6, 2024 Form 4 Insider Report for KalVista Pharmaceuticals, Inc. (KALV)

Role
10%+ Owner
Signature
VHCP Co-Investment Holdings III, LLC, By: VHCP Management III, LLC, Its: Manager, By: /s/ Sherman G. Souther, Authorized Signatory
Stock symbol
KALV
Transactions as of
Feb 6, 2024
Transactions value $
$1,257,829
Form type
4
Date filed
2/8/2024, 08:11 PM
Previous filing
Feb 1, 2024
Next filing
Feb 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KALV Common Stock Purchase $65.9K +4.47K +0.09% $14.74 4.74M Feb 6, 2024 By Funds F1, F2, F3
transaction KALV Common Stock Purchase $755K +51.8K +1.09% $14.56 4.79M Feb 7, 2024 By Funds F3, F4, F5
transaction KALV Common Stock Purchase $437K +29.7K +0.62% $14.70 4.82M Feb 8, 2024 By Funds F3, F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.70 to $14.75 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2 Consists of (i) 1,037,607 shares held by Venrock Healthcare Capital Partners III, L.P. ("VHCP3"); (ii) 103,796 shares held by VHCP Co-Investment Holdings III,LLC ("VHCP Co-3"); and (iii) 3,601,754 shares held by Venrock Healthcare Capital Partners EG, L.P. ("VHCP EG").
F3 VHCP Management III, LLC ("VHCPM3") is the general partner of VHCP3 and the manager of VHCP Co-3 and may be deemed to beneficially own these shares. VHCP Management EG, LLC ("VHCPMEG") is the general partner of VHCPEG and may be deemed to beneficially own these shares. Bong Koh and Nimish Shah are the voting members of VHCPM3 and VHCPMEG and may be deemed to beneficially own these shares. Each of VHCPM3, VHCPMEG and Messrs. Koh and Shah expressly disclaims beneficial ownership over these shares except to the extent of its or his indirect pecuniary interest therein.
F4 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.41 to $14.75 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F5 Consists of (i) 1,051,233 shares held by VHCP3; (ii) 105,158 shares held by VHCP Co-3; and (iii) 3,638,593 shares held by VHCP EG.
F6 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.53 to $14.75 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F7 Consists of (i) 1,059,054 shares held by VHCP3; (ii) 105,940 shares held by VHCP Co-3; and (iii) 3,659,737 shares held by VHCP EG.